SEC Form 4 · accession 0001628280-16-019562
CHAMPIONS ONCOLOGY, INC. · CSBR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David Barry Miller
Officer — Vice President, Finance
Period of report
Jul 21, 2016
Accepted (ET)
Sep 14, 2016 · 1:34 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000771856
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to purchase Common StockF2,F1 | $2.10 | Jul 21, 2016 | A | 5,515 | A | — | Jun 23, 2023 | Common Stock | 5,515 | 5,515 | D |
| Option to purchase Common StockF2,F1 | $2.10 | Jul 21, 2016 | A | 11,251 | A | — | May 22, 2025 | Common Stock | 11,251 | 11,251 | D |
| Option to purchase Common StockF2,F1 | $4.92 | Jul 21, 2016 | D | 6,154 | D | — | Jun 23, 2023 | Common Stock | 6,154 | 0 | D |
| Common StockF2,F1 | $6.96 | Jul 21, 2016 | D | 12,500 | D | — | May 22, 2025 | Common Stock | 12,500 | 0 | D |
Explanation of responses
- F1Fully vested upon grant.
- F2The reporting person agreed to the cancellation of options granted to him on March 16, 2015 and May 22, 2015 in exchange for new options having a lower exercise price.